257 related articles for article (PubMed ID: 18794496)
1. Neuronal surface antigen antibodies in limbic encephalitis: clinical-immunologic associations.
Graus F; Saiz A; Lai M; Bruna J; López F; Sabater L; Blanco Y; Rey MJ; Ribalta T; Dalmau J
Neurology; 2008 Sep; 71(12):930-6. PubMed ID: 18794496
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies to neuronal surface antigens in thyroid antibody-positive and -negative limbic encephalitis.
Tüzün E; Erdağ E; Durmus H; Brenner T; Türkoglu R; Kürtüncü M; Lang B; Akman-Demir G; Eraksoy M; Vincent A
Neurol India; 2011; 59(1):47-50. PubMed ID: 21339658
[TBL] [Abstract][Full Text] [Related]
3. Clinical Characterization of Definite Autoimmune Limbic Encephalitis: A 30-case Series.
Shojima Y; Nishioka K; Watanabe M; Jo T; Tanaka K; Takashima H; Noda K; Okuma Y; Urabe T; Yokoyama K; Hattori N
Intern Med; 2019 Dec; 58(23):3369-3378. PubMed ID: 31434821
[TBL] [Abstract][Full Text] [Related]
4. Voltage-gated potassium channel antibodies in limbic encephalitis.
Pozo-Rosich P; Clover L; Saiz A; Vincent A; Graus F
Ann Neurol; 2003 Oct; 54(4):530-3. PubMed ID: 14520669
[TBL] [Abstract][Full Text] [Related]
5. [Limbic encephalitis and variants related to neuronal cell membrane autoantigens].
Dalmau J
Rinsho Shinkeigaku; 2008 Nov; 48(11):871-4. PubMed ID: 19198103
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of CSF findings in antibody-associated limbic and anti-NMDAR-encephalitis.
Malter MP; Elger CE; Surges R
Seizure; 2013 Mar; 22(2):136-40. PubMed ID: 23318046
[TBL] [Abstract][Full Text] [Related]
7. [Limbic encephalitis: the new cell membrane antigens and a proposal of clinical-immunological classification with therapeutic implications].
Dalmau J; Bataller L
Neurologia; 2007 Oct; 22(8):526-37. PubMed ID: 18000762
[TBL] [Abstract][Full Text] [Related]
8. Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen.
Lancaster E; Lai M; Peng X; Hughes E; Constantinescu R; Raizer J; Friedman D; Skeen MB; Grisold W; Kimura A; Ohta K; Iizuka T; Guzman M; Graus F; Moss SJ; Balice-Gordon R; Dalmau J
Lancet Neurol; 2010 Jan; 9(1):67-76. PubMed ID: 19962348
[TBL] [Abstract][Full Text] [Related]
9. Outcome of limbic encephalitis with VGKC-complex antibodies: relation to antigenic specificity.
Malter MP; Frisch C; Schoene-Bake JC; Helmstaedter C; Wandinger KP; Stoecker W; Urbach H; Surges R; Elger CE; Vincent AV; Bien CG
J Neurol; 2014 Sep; 261(9):1695-705. PubMed ID: 24935858
[TBL] [Abstract][Full Text] [Related]
10. [VGKC antibodies associated with limbic encephalitis].
Soeder BM; Urbach H; Elger CE; Bien CG; Beyenburg S
Nervenarzt; 2005 Jun; 76(6):760-2. PubMed ID: 15586263
[TBL] [Abstract][Full Text] [Related]
11. Voltage-gated potassium channel-associated limbic encephalitis in the West of Scotland: case reports and literature review.
Reid JM; Foley P; Willison HJ
Scott Med J; 2009 Nov; 54(4):27-31. PubMed ID: 20034278
[TBL] [Abstract][Full Text] [Related]
12. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location.
Lai M; Hughes EG; Peng X; Zhou L; Gleichman AJ; Shu H; Matà S; Kremens D; Vitaliani R; Geschwind MD; Bataller L; Kalb RG; Davis R; Graus F; Lynch DR; Balice-Gordon R; Dalmau J
Ann Neurol; 2009 Apr; 65(4):424-34. PubMed ID: 19338055
[TBL] [Abstract][Full Text] [Related]
13. Course and outcome of acute limbic encephalitis with negative voltage-gated potassium channel antibodies.
Samarasekera SR; Vincent A; Welch JL; Jackson M; Nichols P; Griffiths TD
J Neurol Neurosurg Psychiatry; 2007 Apr; 78(4):391-4. PubMed ID: 17098840
[TBL] [Abstract][Full Text] [Related]
14. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis.
Vincent A; Buckley C; Schott JM; Baker I; Dewar BK; Detert N; Clover L; Parkinson A; Bien CG; Omer S; Lang B; Rossor MN; Palace J
Brain; 2004 Mar; 127(Pt 3):701-12. PubMed ID: 14960497
[TBL] [Abstract][Full Text] [Related]
15. Syndrome and outcome of antibody-negative limbic encephalitis.
Graus F; Escudero D; Oleaga L; Bruna J; Villarejo-Galende A; Ballabriga J; Barceló MI; Gilo F; Popkirov S; Stourac P; Dalmau J
Eur J Neurol; 2018 Aug; 25(8):1011-1016. PubMed ID: 29667271
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune limbic encephalitis in 39 patients: immunophenotypes and outcomes.
Bataller L; Kleopa KA; Wu GF; Rossi JE; Rosenfeld MR; Dalmau J
J Neurol Neurosurg Psychiatry; 2007 Apr; 78(4):381-5. PubMed ID: 16980333
[TBL] [Abstract][Full Text] [Related]
17. Supratentorial white matter blurring associated with voltage-gated potassium channel-complex limbic encephalitis.
Urbach H; Rauer S; Mader I; Paus S; Wagner J; Malter MP; Prüss H; Lewerenz J; Kassubek J; Hegen H; Auer M; Deisenhammer F; Ufer F; Bien CG; Baumgartner A
Neuroradiology; 2015 Dec; 57(12):1203-9. PubMed ID: 26293130
[TBL] [Abstract][Full Text] [Related]
18. Voltage-gated potassium channel antibodies associated limbic encephalitis in a patient with invasive thymoma.
Ohshita T; Kawakami H; Maruyama H; Kohriyama T; Arimura K; Matsumoto M
J Neurol Sci; 2006 Dec; 250(1-2):167-9. PubMed ID: 17028029
[TBL] [Abstract][Full Text] [Related]
19. Potassium channel antibodies in two patients with reversible limbic encephalitis.
Buckley C; Oger J; Clover L; Tüzün E; Carpenter K; Jackson M; Vincent A
Ann Neurol; 2001 Jul; 50(1):73-8. PubMed ID: 11456313
[TBL] [Abstract][Full Text] [Related]
20. GABA(B) receptor antibodies in limbic encephalitis and anti-GAD-associated neurologic disorders.
Boronat A; Sabater L; Saiz A; Dalmau J; Graus F
Neurology; 2011 Mar; 76(9):795-800. PubMed ID: 21357831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
